Comment: This should stir things up a lot. Take your role and take action to free the plant from the bonds of manipulation.
By Tom Angell
Global health experts at the United Nations are recommending that marijuana and its key components be formally rescheduled under international drug treaties.
WHO is also moving to make clear that cannabidiol and CBD-focused preparations containing no more than 0.2 percent THC are “not under international control” at all. It had previously been the case that CBD wasn’t scheduled under the international conventions, but the new recommendation is to make that even more clear.
If the recommendation on CBD is adopted, however, it could potentially have far-reaching implications in the U.S. Last year, the Food and Drug Administration (FDA) determined that CBD does not meet the criteria for federal control—except for the fact that international treaties to which the U.S. is party could potentially be construed as requiring it.
“If treaty obligations do not require control of CBD, or if the international controls on CBD change in the future, this recommendation will need to be promptly revisited,” FDA wrote, adding that the U.S. scheduling placement of CBD should be “revisited promptly” if international treaty obligations changed. Under the clarification being recommended by WHO, no one would be able to argue that CBD is globally scheduled.